Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices
Standard
Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices. / Mauri, Victor; Frohn, Thomas; Deuschl, Florian; Mohemed, Kawa; Kuhr, Kathrin; Reimann, Andreas; Körber, Maria Isabel; Schofer, Niklas; Adam, Matti; Friedrichs, Kai; Kuhn, Elmar W; Scholtz, Smita; Rudolph, Volker; Wahlers, Thorsten C W; Baldus, Stephan; Mader, Navid; Schäfer, Ulrich; Rudolph, Tanja K.
In: OPEN HEART, Vol. 7, No. 1, e001164, 10.05.2020.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices
AU - Mauri, Victor
AU - Frohn, Thomas
AU - Deuschl, Florian
AU - Mohemed, Kawa
AU - Kuhr, Kathrin
AU - Reimann, Andreas
AU - Körber, Maria Isabel
AU - Schofer, Niklas
AU - Adam, Matti
AU - Friedrichs, Kai
AU - Kuhn, Elmar W
AU - Scholtz, Smita
AU - Rudolph, Volker
AU - Wahlers, Thorsten C W
AU - Baldus, Stephan
AU - Mader, Navid
AU - Schäfer, Ulrich
AU - Rudolph, Tanja K
N1 - © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/5/10
Y1 - 2020/5/10
N2 - OBJECTIVE: Residual paravalvular regurgitation (PVR) has been associated to adverse outcomes after transcatheter aortic valve replacement (TAVR). This study sought to evaluate the impact of device landing zone (DLZ) calcification on residual PVR after TAVR with different next-generation transcatheter heart valves.METHODS: 642 patients underwent TAVR with a SAPIEN 3 (S3; n=292), ACURATE neo (NEO; n=166), Evolut R (ER; n=132) or Lotus (n=52). Extent, location and asymmetry of DLZ calcification were assessed from contrast-enhanced CT imaging and correlated to PVR at discharge.RESULTS: PVR was ≥moderate in 0.7% of S3 patients, 9.6% of NEO patients, 9.8% of ER patients and 0% of Lotus patients (p<0.001), and these differences remained after matching for total DLZ calcium volume. The amount of DLZ calcium was significantly related to the degree of PVR in patients treated with S3 (p=0.045), NEO (p=0.004) and ER (p<0.001), but not in Lotus patients (p=0.698). The incidence of PVR ≥moderate increased significantly over the tertiles of DLZ calcium volume (p=0.046). On multivariable analysis, calcification of the aortic valve cusps, LVOT calcification and the use of self-expanding transcatheter aortic valve implantation (TAVI) prostheses emerged as predictors of PVR.CONCLUSIONS: The susceptibility to PVR depending on the amount of calcium was mainly observed in self-expanding TAVI prostheses. Thus, DLZ calcification is an important factor to be considered in prosthesis selection for each individual patient, keeping in mind the trade-off between PVR reduction, risk of new pacemaker implantation and unfavourable valve ha emodynamics.
AB - OBJECTIVE: Residual paravalvular regurgitation (PVR) has been associated to adverse outcomes after transcatheter aortic valve replacement (TAVR). This study sought to evaluate the impact of device landing zone (DLZ) calcification on residual PVR after TAVR with different next-generation transcatheter heart valves.METHODS: 642 patients underwent TAVR with a SAPIEN 3 (S3; n=292), ACURATE neo (NEO; n=166), Evolut R (ER; n=132) or Lotus (n=52). Extent, location and asymmetry of DLZ calcification were assessed from contrast-enhanced CT imaging and correlated to PVR at discharge.RESULTS: PVR was ≥moderate in 0.7% of S3 patients, 9.6% of NEO patients, 9.8% of ER patients and 0% of Lotus patients (p<0.001), and these differences remained after matching for total DLZ calcium volume. The amount of DLZ calcium was significantly related to the degree of PVR in patients treated with S3 (p=0.045), NEO (p=0.004) and ER (p<0.001), but not in Lotus patients (p=0.698). The incidence of PVR ≥moderate increased significantly over the tertiles of DLZ calcium volume (p=0.046). On multivariable analysis, calcification of the aortic valve cusps, LVOT calcification and the use of self-expanding transcatheter aortic valve implantation (TAVI) prostheses emerged as predictors of PVR.CONCLUSIONS: The susceptibility to PVR depending on the amount of calcium was mainly observed in self-expanding TAVI prostheses. Thus, DLZ calcification is an important factor to be considered in prosthesis selection for each individual patient, keeping in mind the trade-off between PVR reduction, risk of new pacemaker implantation and unfavourable valve ha emodynamics.
KW - Aged
KW - Aged, 80 and over
KW - Aortic Valve/diagnostic imaging
KW - Aortic Valve Insufficiency/diagnostic imaging
KW - Aortic Valve Stenosis/diagnostic imaging
KW - Calcinosis/diagnostic imaging
KW - Female
KW - Germany
KW - Heart Valve Prosthesis
KW - Hemodynamics
KW - Humans
KW - Male
KW - Prosthesis Design
KW - Recovery of Function
KW - Retrospective Studies
KW - Risk Assessment
KW - Risk Factors
KW - Severity of Illness Index
KW - Time Factors
KW - Transcatheter Aortic Valve Replacement/adverse effects
KW - Treatment Outcome
U2 - 10.1136/openhrt-2019-001164
DO - 10.1136/openhrt-2019-001164
M3 - SCORING: Journal article
C2 - 32393655
VL - 7
JO - OPEN HEART
JF - OPEN HEART
SN - 2053-3624
IS - 1
M1 - e001164
ER -